Clinical Trial Update: A Bioequivalence Study of Two Different PEG-rhGH Preparations [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing two PEG-rhGH preparations completed in pediatric growth hormone deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Pegylated recombinant human growth hormone (PEG-rhGH) - Preparation 1
• Pegylated recombinant human growth hormone (PEG-rhGH) - Preparation 2

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Pediatric Growth Hormone Deficiency (PGHD) | Phase 1 | Status: COMPLETED